Follow The Filings

ICLR ICON

ICON earnings company data as of 4:45 AM ET 10/9

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 28 Oct EPS 2.44 — —
Rev — — —

Insider trades

Open-market buys and sales by ICLR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ICLR insider trades
  • None no insider bought on the open market
  • $2.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. John Dr Climax Director
    Sale
    $876K 5,005 shares at $175.00 71% of stake
    Traded Sep 16 Filed Sep 18
    ↗
  2. Eugene Pacelli McCague Director
    Sale
    $570K 3,255 shares at $175.00 46% of stake
    Traded Sep 17 Filed Sep 18
    ↗
  3. Ronan Martin Murphy Director
    Sale
    $876K 5,005 shares at $175.00 57% of stake
    Traded Sep 17 Filed Sep 18
    ↗

Also filed in the last 12 months, not counted as buying or selling: 34 sales to cover taxes and 13 option exercises.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
6-K Filing Doc
20-F Filing Doc
6-K/A Filing Doc
6-K Filing Doc
6-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.